Product Information
| Product Name | FOXO4-DRI |
| Batch Number | PH-FOXO4-001-2024-1646 |
| Analysis Date | 2024-11-15 |
Analytical Methods
- HPLC-UV
- Mass Spectrometry
- Amino Acid Analysis
- Endotoxin Testing
Test Results
| Parameter | Specification | Result | Status |
|---|---|---|---|
| Purity (HPLC) | ≥98.0% | ≥99% | Conforms |
| Molecular Mass | 3400 Da | Conforms | Conforms |
| Peptide Content | ≥80% | 85.3% | Conforms |
| Water Content | ≤8% | 4.7% | Conforms |
| Endotoxin | <1 EU/mg | <0.1 EU/mg | Conforms |
Conclusion
The above batch has been tested according to documented procedures and meets all specifications. This certificate documents the analytical results for the referenced batch only.
Peptide Hackers Laboratory Standards for FOXO4-DRI
FOXO4-DRI is synthesized and analyzed in controlled laboratory environments operating under documented quality management systems aligned with ISO 9001:2015 principles. This ensures standardized procedures, batch traceability, record control, and consistent quality oversight across production and testing.
Each batch of FOXO4-DRI undergoes analytical verification using High Performance Liquid Chromatography HPLC to assess purity and Mass Spectrometry MS to confirm molecular identity. The Certificate of Analysis reflects the actual test results for the specific lot shown.
ISO 9001:2015 relates to how quality systems are managed and audited. It does not represent pharmaceutical grade GMP. FOXO4-DRI is not marketed as an FDA approved drug and is supplied strictly for research purposes only.
This document is provided for informational and research reference purposes. No purchase, ordering, or commercial transaction information is contained herein.